Government viewpoint: U.S. Food & Drug Administration: Pacemakers, ICDs and MRI

PACE - Pacing and Clinical Electrophysiology

Volumn 28, Issue 4, 2005, Pages 268-269

  Faris, Owen P ^a   Shein, Mitchell J ^a,b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Div Cardiovasc Devices (HFZ 450)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARRHYTHMOGENESIS; ARTIFICIAL HEART PACEMAKER; DEFIBRILLATOR; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEATING; NUCLEAR MAGNETIC RESONANCE IMAGING; PACEMAKER ELECTRODE; RISK ASSESSMENT; SAFETY;

DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT SAFETY; HUMANS; MAGNETIC RESONANCE IMAGING; PACEMAKER, ARTIFICIAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 18044383757     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2005.50035.x     Document Type: Editorial

References (6)

1. Martin ET, Coman JA, Shellock FG, et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004;43:1315-1324.
2. Roguin A, Zviman MM, Meininger GR, et al. Modern pacemaker and implantable cardioverter/denbrillator systems can be magnetic resonance imaging safe. Circulation 2004; 110:475-482.
3. Gimbel JR, Kanal E. Can patients with implantable pacemakers safely undergo magnetic resonance imaging? J Am Coll Cardiol 2004; 43:1325-1327.
4. Sommer T, Vahlhaus C, Lauck G, et al. MR imaging and cardiac pacemakers: In vitro evaluation and in vivo studies in 51 patients at 0.5 T. Radiology 2000; 215:869-879.
5. Baker KB, Tkach JA, Nyenhuis JA, et al. Evaluation of specific absorption rate as a dosimeter of MRI-related implant heating. J Magn Reson Imaging 2004; 315-320.
6. Fiek M, Remp T, Reithmann C, Steinbeck G. Complete loss of ICD programmability after magnetic resonance imaging. PACE 2004; 27:1002-1004.